Miscellaneous
Managing a chronic condition like multiple sclerosis can be complicated. In the second part of Astrid’s story, we hear about her experiences with disease symptoms and complications, treatment, supportive therapies, lifestyle changes, and support networks, all of which play a part in helping her and others with MS live well. We’ll again hear from Dr. John Parratt about what it’s like managing the condition, including explanations of treatment types and strategies for getting the support you need as a person living with MS. This episode is kindly supported by MS Australia and is sponsored by Roche Australia (Sydney). Material number EC-AU-9437, prepared Apr2020. Episode References: MS Australia. Symptoms. Available at: https://www.msaustralia.org.au/about-ms/symptoms. Accessed April 2020. MedicineNet. Medical Definition of Proprioception. Available at: https://www.medicinenet.com/script/main/art.asp?articlekey=6393. Accessed April 2020. International Association for the study of pain. IASP Terminology – Neuropathic pain. Available at: https://www.iasp-pain.org/terminology?navItemNumber=576#Neuropathicpain. Accessed April 2020. WebMD. What Are the Side Effects of Pain Medication? Available at: https://www.webmd.com/pain-management/pain-medication-side-effects#2. Accessed April 2020. MS Australia. Medications & Treatments. Available at: https://www.msaustralia.org.au/about-ms/medications-treatments. Accessed April 2020. MS Australia. Understanding Multiple Sclerosis – An Introductory Guide. Available at: https://www.msaustralia.org.au/publications/understanding-ms-introductory-guide. Accessed March 2020. MS Australia. Diet & Nutrition. Available at: https://www.msaustralia.org.au/wellbeing-ms/diet-nutrition. Accessed April 2020. Exercise is Medicine Australia Factsheet. Available at: http://exerciseismedicine.com.au/wp-content/uploads/2019/12/Factsheet-MS-BRIEF-VERSION-2014.pdf. Accessed April 2020. Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am. 2007;30(4):803–817. MS Research Australia. MS Treatments. Available at: https://msra.org.au/treatments/. Accessed April 2020. Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies JM, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E. A new era in the treatment of multiple sclerosis. Medical Journal of Australia 2015; 203(3): 139-141. Clanet MC, Wolinsky JS, Ashton RJ, Hartung HP, Reingold SC. Risk evaluation and monitoring in multiple sclerosis therapeutics. Mult Scler 2014; 20(10): 1306-1311. Halabchi F, Alizadeh Z, Sahraian MA, Abolhasani M. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol 2017; 17(1): 185. Klotz L, Havla J, Schwab N, Hohlfeld R, Barnett M, Reddel S, Wiendl H. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment. Ther Adv Neurol Disord 2019; 12: 1756286419836571. Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFalpha, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine 2017; 57(2): 262-271. Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis - success from bench to bedside. Nat Rev Neurol 2019; 15(1): 53-58. Zimmer P, Bloch W, Schenk A, Oberste M, Riedel S, Kool J, Langdon D, Dalgas U, Kesselring J, Bansi J. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial. Mult Scler 2018; 24(12): 1635-1644.